The House Select Subcommittee on the Coronavirus Pandemic held its first hearing on the origins of the virus. The panel, formed by a Republican majority in the House of Representatives, is aiming to establish how the coronavirus emerged. (BBC)

The COVID-19 lab leak fight obscured the global rise of high-security biolabs. There are more and more high-containment labs being built around the world — and no universal agreement on how to regulate or monitor them. (Bloomberg)

Bindi Irwin shared her endometriosis diagnosis in an effort to raise awareness after getting ‘validation for years of pain.’ While she wrote that she felt unsure about disclosing her experience, Irwin said in an Instagram post that she wanted to help others with it who are struggling to receive treatment. (NBC News)

Opko Health shares rose on news of a Merck deal for its experimental Epstein-Barr vaccine. Merck will take over the clinical and regulatory activities related to the vaccine, as well its commercialization once the drugmaker files a joint application with Opko unit ModeX Therapeutics to test it in humans, the company said. (Reuters)

Zymeworks posted a revenue beat in its latest earnings released Wednesday. The Vancouver, British Columbia-based clinical-stage biotechnology company said its quarterly earnings came in at $309.4 million, or $4.65 a share, compared with a loss of $39.2 million, or 95 cents a share, in the same quarter last year. Analysts polled by FactSet were looking for earnings of $169.2 million, or $1.88 a share. (MarketWatch)